AMAG Pharmaceuticals (Intrarosa) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

AMAG Pharmaceuticals (Intrarosa) General Information

Description

Rights to a steroidal drug intended for the treatment of moderate to severe dyspareunia. The drug is used to treat painful sexual intercourse for women after menopause.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 1100 Winter Street
  • Suite 3000
  • Waltham, MA 02451
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AMAG Pharmaceuticals (Intrarosa) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AMAG Pharmaceuticals (Intrarosa)‘s full profile, request access.

Request a free trial

AMAG Pharmaceuticals (Intrarosa) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore AMAG Pharmaceuticals (Intrarosa)‘s full profile, request access.

Request a free trial